Please ensure Javascript is enabled for purposes of website accessibility

Bluebird Bio(BLUE)

Nasdaq Global Select

BLUE
Bluebird Bio Stock Quote
$3.27 -$0.08 -2.4%
Price as of May 20, 2022, 4:00 p.m. ET View Interactive BLUE Charts

Bluebird Bio is a development-stage biotechnology company focused on gene therapy, gene editing, and cancer immunotherapy.

Interactive Chart


Compare BLUE Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
BLUE
Bluebird Bio
$3.27 $234M -82.4% -93.4%
NVTA
$3.63 $832M -86.1% -58.0%
EDIT
$11.02 $756M -67.0% -37.3%
CMPS
$8.36 $355M -76.1%
KOD
$6.96 $359M -91.7%

News & Analysis: Bluebird Bio

The Fool has written over 200 articles on Bluebird Bio.

All

Market Moves

Podcasts



Is Bluebird Bio a Buy?

The expected upcoming catalysts might not be all that the company needs.









Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.